About SOMAÍ
compassionate care scientifically crafted
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
Our Product Categories
For patients
For partners
Company News
SOMAÍ to develop Bedrocan EU-GMP Cannabis Extracts for Global Medical Markets.
Lisbon, Portugal — [21 April, 2026] — SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines,…
Read more
Airo Medical Inhalation Device Launches in Germany with SOMAÍ EU-GMP Inhalation Extracts
The CE-certified device, paired with SOMAÍ’s EU-GMP inhalation extracts, is among the first cannabis inhalation medical devices available in Europe’s…
Read more
Portugal is the EU Cannabis Leader: But the Lead is Being Threatened
Portugal has long been the pioneer and undisputed leader in the EU cannabis markets. We are home to the biggest…
Read more
Boom! The Age of EU-GMP Medical Cannabis is Here: The Global Race is On
For two decades, the fight to acknowledge cannabis as a legitimate medicine in the USA has stumbled through a lobbying…
Read more
It’s time for Australia to enter thenext phase of adolescence and startbuilding for the long term
Australia isn’t in a race to the bottom on price, but in a race for operational efficiency, argues SOMAÍ Pharmaceuticals…
Read more
SOMAÍ Secures Product and Distribution Authorization in Portugal
Lisbon, Portugal — [20 January 2026] — SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines,…
Read more
SOMAÍ and Lusófona University Publish Peer-Reviewed Study Confirming Method for Batch-to-Batch Consistency in Full-Spectrum Cannabis Oils
SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, together with Universidade Lusófona, has published their…
Read more
SOMAÍ Expands Partnership with Dascoli Pharma AG to Launch Mint Oral Solutions Line in Switzerland
SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines, announces the launch of its Mint Oral…
Read more
EU-certified medical vaporizers enter the market: setting a new regulatory standard.
A key difference between a medically certified oil vaporizer and a non-medically approved one lies in their regulatory standard. Non-medical…
Read more
Spain Takes a Major Step Toward Pharmaceutical-Grade Cannabis Regulation: A New Standard for Europe
Spain’s Royal Decree on Medicinal Cannabis is now official, a long-awaited and highly significant move that finally integrates cannabis-based medicines…
Read more
SOMAÍ Adds International Lifestyle Brand Cookies to Global Medical Cannabis Markets
Lisbon, Portugal — [12 November 2025] — Cookies, the most globally recognized cannabis brand, is entering global medical markets with…
Read more
Airo Brands Announces CE-Certified Medical Inhalation Device in Partnership with SOMAÍ
AIRO BRANDS, Inc. (“Airo”), a U.S. multi-state CPG company focused on proprietary cannabis products, in partnership with Jupiter Research LLC,…
Read more
Global Cannabis See-Saw: Surging Demand Meets Tightening Regulations
The global cannabis industry has experienced both great success and significant challenges in 2025. Volumes are surging and new countries…
Read more
MEDITERRANEO – Derrière les serres du Portugal, une industrie légale du cannabis médical
En quelques années, le Portugal est devenu le deuxième producteur mondial de cannabis médical. Grâce à sa législation, il attire…
Read more
Taking Cannabis Global: Inside Somai Pharmaceuticals’ Multi-Country Strategy
In an industry defined by local operators struggling to stay afloat and confined within their borders, Michael Sassano, founder and…
Read more
Taking Cannabis Global: Inside Somai Pharmaceuticals’ Multi-Country Strategy
In an industry defined by local operators struggling to stay afloat and confined within their borders, Michael Sassano, founder and…
Read more
Australia’s GMP mirage: why ‘EU-GMP equivalent’ fails the global cannabis test
SOMAÍ chairman and interim CEO Michael Sassano says many Australian producers have work to do before they can compete on…
Read more
Thai flower in Australia: a tale of two contrasting worlds
Australia was the first global market to get a taste of Thai flower. The rumour mill is abuzz with local…
Read more
Pioneering Progress: How Italy’s Medical Cannabis Market is Evolving
Italy has long been one of the oldest European cannabis markets, which brought access to medical patients since 2015. Although…
Read more
SOMAÍ Continues Global Expansion with Launch in Italy Through Materia Medica Partnership
SOMAÍ, a leading EU-GMP vertically integrated Multi-Country Operator (MCO), continues its rapid expansion into key global markets with its official…
Read more